Exam 3 Part IV Flashcards
what patients would be especially vulnerable to an increase in PVR 2/2 N2O use
- pts with pulmonary htn 2. neonates with bronchopulmonary dysplasia and/or RSV 3. those with congenital heart defects (–> R-to-L shunt)
respiratory effects of N2O
- mild decrease in Tv 2. mild increase in RR 3. hypoxic respiratory drive decreased 4. ventilatory response to increased CO2 affected
renal/hepatic effects of N2O
- no significant effects on kidney 2. mild decrease in hepatic blood flow
neuromuscular effects of N2O
- does NOT provide significant muscle relax 2. increased muscle tone with high concentrations 3. does NOT trigger MH
hematologic effects of N2O
- inhibits enzymes that are vitamin B12 dependent (methionin synthetase) 2. leads to bone marrow suppression 3. peripheral neuropathies 4. & pernicious anemia
T/F: N2O causes increase uterine smM contractility
false; no effect on uterine smM
fetal effects of N2O
- increased incidence of spontaneous abortion with chronic exposure to N2O 2. may be hazardous to fetus esp during 1st trimester
what anatomical areas are “compliant spaces” and would have an increase in volume with the use of N2O
- GI tract 2. pneumoperitoneum 3. pneumothorax 4. air emboli
principle objective of inhlational anesthesia
- achieve a constant and optimal partial pressure of the agent
partial pressure gradients that guide INH anesthetic uptake
- anesthesia machine 2. alveolar 3. blood 4. brain
the goal with INH partial pressure gradients is for the _______________ to = ______________
inspired pressure; alveolar pressure
input of INH agent into alveoli is dependent on
- anesthesia machine 2. inspired partial pressure 3. alveolar ventilation
uptake of INH agent from alveoli to blood is dependent on
- solubility of the gas 2. CO 3. alveolar to venous partial pressure gradient
order of pressure gradients for inhalational agents
Pressure device (PD) - pressure inspired (PI) - Pressure alveoli (PA) - pressure arterial (Pa) - pressure brain (Pbr) same order with fraction
doubling the CO _________________ the time to uptake of INH agent
doubles
Et of INH agent = ________________ of the agent
partial pressure
pt will have awareness at a MAC < ___________
0.7
factors that influence tissue uptake of INH agent
- tissue solubility 2. tissue blood flow 3. Pa-Pbr partial pressure difference
you should have equilibration of INH agent Pa with VRG within _______________min
8-Apr
you should have equilibration of INH agent Pa with muscle and skin group (MG) within ___________________
1-4 hours
you should have equilibration of INH agent Pa and fat group within ____________
> 24 hours
your MAC should not get below ___________ without reversing your muscle relaxant
0.7
elimination of INH agent is determined by?
- length of administration of agent 2. solubility of agent (elim time decreased with less plasma soluble agents)
rate of decrease of INH in Pbr is reflected by the ____________
PA
what is the effect of N2O is discontinued abruptly
- reversal of partial pressure gradients –> reverse concentration effect 2. high volume of N2O enters the alveoli from capillary flow –> displacing O2 from alveoli –> decreasing PaCO2 3. dilutes PaCO2 –> decreased stimulus to breathe all leads to diffusion hypoxia
how can you avoid diffusion hypoxia with N2O
filling lungs with 100% FiO2 at the end of a case
Tec6 heats the vaporizer to _______________ creating VP = ___________atm
39 C; 2
what is the MOA of all local anesthetics?
they block voltage gated sodium channels
uses of local anesthetics
- local infiltration (hernia repair) 2. peripheral/regional blocks 3. neuraxial blocks 4. acute or chronic pain 5. IV injection for arrhythmias
all currently available LA consists of a _______________ ring + ___________
lipophillic phenyl ring; tertiary (majority)/quaternary amine
what determines whether a LA is an amide or an ester
the bond btween the benzene ring and the carbon group
tertiary amine LA have more _______________ effects than those that are quaternary
toxic CNS
which LA are esters
- procaine (novicaine) 2. chloroprocaine** (nesacaine) 3. tetracaine (pontocaine) 4. cocaine 5. benzocaine**
_______________ is available commercially as ambesol and origel
benzocaine
which LA are amides
- lidocaine (xylocaine)** 2. mepivacaine (carbocaine) 3. prilocaine 4. bupivacaine** (marcaine, sensorcaine) 5. levobupivicaine (chirocaine) 6. ropivicaine (naropin)** 7. articaine
which LA has the highest risk of toxicity
bupivicaine
metabolism of ester LA
- catalyzed by plasma tissue cholinesterases via hydrolysis 2. occurs throughout the body in the blood 3. rapid metabolism
which ester is NOT metaboized by plasma and tissue cholinesterases
cocaine
what is the longest acting ester
tetracaine
DOA of ester LA
short due to rapid metabolism